CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Why Is Jazz (JAZZ) Down 6.9% Since Last Earnings Report?

EarningsNegative
AI Analysis

Summary

Jazz Pharmaceuticals stock has declined 6.9% since its last earnings report. The article provides limited details on the specific drivers of the price decline.

Importance:2/10
Sentiment:
-0.30
earningsstock_performanceprice_decline
Related Companies

Read the original article

Published by yahoo_finance on September 2, 2026 3:30 PM

Read Original